Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...

This review uncovers how aging reshapes immunoglobulins, particularly IgG, IgM, and IgA, driving inflammation, cellular ...

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, ...

Findings show that Telomir-1 restores the body’s natural tumor suppressor defenses by reversing abnormal DNA methylation of ...

A protein notorious for its role in Alzheimer’s disease may hold the key to supercharging the aging immune system, according ...

MIAMI, FLORIDA / ACCESS Newswire / August 28, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), a preclinical-stage biotechnology company developing therapies that target the root mechanisms of ...

At first glance, Alzheimer's disease and cancer have little in common. One erodes memory, while the other consumes the body.

In 2024, Americans spent more than $21 billion on chocolate treats -- and while 40% of folks say milk chocolate is their favorite, 28% like dark chocolate best. And it's the dark chocolate that ...

As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive ...

A Lancet study has found cancer cases worldwide surged from 9 to 18.5 million since 1990, and could rise to 30.5 million by ...

Childhood cancer treatments can accelerate biological aging, increasing risks for long-term health issues like heart disease and hypertension. Epigenetic age acceleration measures the difference ...

In vitro findings reveal Telomir-1’s dual action: targeting DNA methylation switches and cutting into the Wnt “fuel line” that drives cancer growth. MIAMI, FLORIDA / ACCESS Newswire / August 28, 2025 ...